Wechselwirkungen von Bismutsubsalicylat

Bismutsubsalicylat (Pepto-Bismol, Kaopectate), ein Salicylat, hat in den von uns erfassten FDA-Fachinformationen und Faktenblättern 77 dokumentierte Wechselwirkungen: 25 schwerwiegende, 48 mittelschwere, 4 geringfügige und 0, bei denen eine Fachinformation keine relevante Wechselwirkung berichtet. Jeder Eintrag unten zitiert den Satz, auf dem er beruht. Diese Medikamentenseite ist ein Ausgangspunkt, kein Urteil über Ihre persönliche Situation.

So sieht Bismutsubsalicylat aus

Alle 15 Varianten
Bismutsubsalicylat 262 mg Tablette: rosa, rund, 16 mm, Prägung Pepto auf der einen Seite und Bismol auf der anderen.
Pepto / Bismol
262 mg · rosa · rund · 16 mm
Select Consumer Group
Bismutsubsalicylat 262 mg Tablette: rosa, oval, 16 mm, Prägung 44 auf der einen Seite und 346 auf der anderen.
44 / 346
262 mg · rosa · oval · 16 mm
Wal-Mart Stores
Bismutsubsalicylat 262 mg Kapsel: rosa, 12 mm, ohne Prägung.
Keine Prägung
262 mg · rosa · Kapsel · 12 mm
Vivunt
Bismutsubsalicylat 262 mg Kapsel: rosa, 14 mm, Prägung PB.
PB
262 mg · rosa · Kapsel · 14 mm
The Procter & Gamble Manuf…

Darstellungen nach den Produktangaben der FDA-Fachinformationen: Farbe, Form, Größe und Prägung. 15 dokumentierte Varianten von 15 Anbietern.

Wechselwirkungen laut Fachinformation

Schwerwiegende Wechselwirkungen (25)

  • AcetylsalicylsäureNSARSchwerwiegend

    Do not take if you are allergic to salicylates (including aspirin) taking other salicylate products Do not use if you have an ulcer a bleeding problem bloody or black stool Ask a doctor before use if you have fever mucus in the stool Ask a doctor or pharmacist before use if you are taking any drug for diabetes gout arthritis anticoagulation (thinning the blood)… (Fachinformation zu Bismutsubsalicylat, Warnhinweise)

  • Acetylsalicylsäure und DipyridamolThrombozytenaggregationshemmerSchwerwiegend

    Do not take if you are allergic to salicylates (including aspirin) taking other salicylate products Do not use if you have an ulcer a bleeding problem bloody or black stool Ask a doctor before use if you have fever mucus in the stool Ask a doctor or pharmacist before use if you are taking any drug for diabetes gout arthritis anticoagulation (thinning the blood)… (Fachinformation zu Bismutsubsalicylat, Warnhinweise)

  • Do not take if you are allergic to salicylates (including aspirin) taking other salicylate products Do not use if you have an ulcer a bleeding problem bloody or black stool Ask a doctor before use if you have fever mucus in the stool Ask a doctor or pharmacist before use if you are taking any drug for diabetes gout arthritis anticoagulation (thinning the blood)… (Fachinformation zu Bismutsubsalicylat, Warnhinweise)

  • Do not take if you are allergic to salicylates (including aspirin) taking other salicylate products Do not use if you have an ulcer a bleeding problem bloody or black stool Ask a doctor before use if you have fever mucus in the stool Ask a doctor or pharmacist before use if you are taking any drug for diabetes gout arthritis anticoagulation (thinning the blood)… (Fachinformation zu Bismutsubsalicylat, Warnhinweise)

  • CelecoxibNSARSchwerwiegend

    Intervention: The concomitant use of Celecoxib with other NSAIDs or salicylates is not recommended. (Fachinformation zu Celecoxib, Arzneimittelwechselwirkungen)

  • DiclofenacNSARSchwerwiegend

    Intervention: The concomitant use of diclofenac with other NSAIDs or salicylates is not recommended. (Fachinformation zu Diclofenac, Arzneimittelwechselwirkungen)

  • Intervention: The concomitant use of diclofenac sodium/misoprostol with other NSAIDs or salicylates is not recommended. (Fachinformation zu Diclofenac und Misoprostol, Arzneimittelwechselwirkungen)

  • FenoprofenNSARSchwerwiegend

    Intervention: The concomitant use of fenoprofen with other NSAIDs or salicylates is not recommended. (Fachinformation zu Fenoprofen, Arzneimittelwechselwirkungen)

  • FlurbiprofenNSARSchwerwiegend

    Intervention: The concomitant use of flurbiprofen with other NSAIDs or salicylates is not recommended. (Fachinformation zu Flurbiprofen, Arzneimittelwechselwirkungen)

  • Hydrocodon und IbuprofenOpioidSchwerwiegend

    The concomitant use of ibuprofen with other NSAIDs or salicylates is not recommended. (Fachinformation zu Hydrocodon und Ibuprofen, Arzneimittelwechselwirkungen)

  • IbuprofenNSARSchwerwiegend

    Intervention: The concomitant use of ibuprofen with other NSAIDs or salicylates is not recommended. (Fachinformation zu Ibuprofen, Arzneimittelwechselwirkungen)

  • Ibuprofen und FamotidinNSARSchwerwiegend

    Intervention: The concomitant use of ibuprofen and famotidine tablet with other NSAIDs or salicylates is not recommended. (Fachinformation zu Ibuprofen und Famotidin, Arzneimittelwechselwirkungen)

  • IndometacinNSARSchwerwiegend

    Intervention: The concomitant use of indomethacin with other NSAIDs or salicylates, especially diflunisal, is not recommended. (Fachinformation zu Indometacin, Arzneimittelwechselwirkungen)

  • MefenaminsäureNSARSchwerwiegend

    Intervention: The concomitant use of mefenamic acid with other NSAIDs or salicylates is not recommended. (Fachinformation zu Mefenaminsäure, Arzneimittelwechselwirkungen)

  • MeloxicamNSARSchwerwiegend

    Intervention: The concomitant use of meloxicam with other NSAIDs or salicylates is not recommended. (Fachinformation zu Meloxicam, Arzneimittelwechselwirkungen)

  • NaproxenNSARSchwerwiegend

    Intervention: The concomitant use of naproxen with other NSAIDs or salicylates is not recommended. (Fachinformation zu Naproxen, Arzneimittelwechselwirkungen)

  • Naproxen und EsomeprazolNSARSchwerwiegend

    Intervention: The concomitant use of naproxen and esomeprazole magnesium delayed-release tablets with other NSAIDs or salicylates is not recommended. (Fachinformation zu Naproxen und Esomeprazol, Arzneimittelwechselwirkungen)

  • Do not take if you are allergic to salicylates (including aspirin) taking other salicylate products Do not use if you have an ulcer a bleeding problem bloody or black stool Ask a doctor before use if you have fever mucus in the stool Ask a doctor or pharmacist before use if you are taking any drug for diabetes gout arthritis anticoagulation (thinning the blood)… (Fachinformation zu Bismutsubsalicylat, Warnhinweise)

  • OxaprozinNSARSchwerwiegend

    Intervention: The concomitant use of oxaprozin with other NSAIDs or salicylates is not recommended. (Fachinformation zu Oxaprozin, Arzneimittelwechselwirkungen)

  • Paracetamol und IbuprofenNSARSchwerwiegend

    Intervention: The concomitant use of ibuprofen with other NSAIDs or salicylates is not recommended. (Fachinformation zu Paracetamol und Ibuprofen, Arzneimittelwechselwirkungen)

  • PhysostigminCholinesterasehemmerSchwerwiegend

    Contraindications: ANTICHOLIUM ® should not be used in the presence of hypersensitivity to physostigmine salicylate, bronchial asthma, ulcers associated with tissue destruction (gangrene), coronary heart disease, constipation (mechanical obstipation), mechanical ischuria (urinary retention), hereditary form of muscle atrophy (myotonic dystrophy), closed traumatic… (Fachinformation zu Physostigmin, Gegenanzeigen)

  • PiroxicamNSARSchwerwiegend

    Intervention: The concomitant use of piroxicam with other NSAIDs or salicylates is not recommended. (Fachinformation zu Piroxicam, Arzneimittelwechselwirkungen)

  • ProbenecidSchwerwiegend

    In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (Fachinformation zu Probenecid, Warnhinweise)

  • In patients on probenecid and colchicine the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (Fachinformation zu Probenecid und Colchicin, Warnhinweise)

  • Sumatriptan und NaproxenTriptanSchwerwiegend

    Intervention: The concomitant use of naproxen with other NSAIDs or salicylates is not recommended. (Fachinformation zu Sumatriptan und Naproxen, Arzneimittelwechselwirkungen)

Mittelschwere Wechselwirkungen (48)

  • AdapalenRetinoidMittelschwer

    Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with Adapalene Cream, 0.1%. (Fachinformation zu Adapalen, Arzneimittelwechselwirkungen)

  • BrinzolamidCarboanhydrasehemmerMittelschwer

    • Rare instances of acid-base alterations have occurred with high-dose salicylate therapy. (Fachinformation zu Brinzolamid, Arzneimittelwechselwirkungen)

  • BromocriptinDopaminagonistMittelschwer

    Therefore, CYCLOSET may increase the unbound fraction of other concomitantly used highly protein-bound therapies (e.g., salicylates, sulfonamides, chloramphenicol and probenecid), which may alter their effectiveness and risk for side effects. (Fachinformation zu Bromocriptin, Arzneimittelwechselwirkungen)

  • CiprofloxacinFluorchinolonMittelschwer

    NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing. (Fachinformation zu Ciprofloxacin, Arzneimittelwechselwirkungen)

  • Desogestrel und Ethinylestradiolorales KontrazeptivumMittelschwer

    COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine. (Fachinformation zu Desogestrel und Ethinylestradiol, Arzneimittelwechselwirkungen)

  • DexamethasonKortikosteroidMittelschwer

    The clearance of salicylates may be increased with concurrent use of corticosteroids. (Fachinformation zu Dexamethason, Arzneimittelwechselwirkungen)

  • DiclofenamidCarboanhydrasehemmerMittelschwer

    Concomitant Use of Aspirin or Other Salicylates Carbonic anhydrase inhibitors, including KEVEYIS, can cause metabolic acidosis [see Warnings and Precautions (5.4) ] , which can increase the risk of salicylate toxicity. (Fachinformation zu Diclofenamid, Warnhinweise und Vorsichtsmaßnahmen)

  • DorzolamidCarboanhydrasehemmerMittelschwer

    High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (Fachinformation zu Dorzolamid, Arzneimittelwechselwirkungen)

  • Dorzolamid und TimololCarboanhydrasehemmerMittelschwer

    High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (Fachinformation zu Dorzolamid und Timolol, Arzneimittelwechselwirkungen)

  • CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam. (Fachinformation zu Etonogestrel und Ethinylestradiol, Arzneimittelwechselwirkungen)

  • FludrocortisonKortikosteroidMittelschwer

    Rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high-dose aspirin therapy. (Fachinformation zu Fludrocortison, Arzneimittelwechselwirkungen)

  • FosphenytoinAntiepileptikumMittelschwer

    …sulfamethoxazole-trimethoprim Other Acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen, fluvastatin, isoniazid, methylphenidate, phenothiazines, salicylates, ticlopidine, tolbutamide, trazodone, warfarin Drugs that may decrease phenytoin serum levels Antineoplastic agents usually in combination Bleomycin, carboplatin, cisplatin,… (Fachinformation zu Fosphenytoin, Arzneimittelwechselwirkungen)

  • FurosemidSchleifendiuretikumMittelschwer

    • Salicylates : Risk of salicylate toxicity ( 7.1 ) (Fachinformation zu Furosemid, Arzneimittelwechselwirkungen)

  • GlibenclamidSulfonylharnstoffMittelschwer

    …Interactions The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, ACE inhibitors, disopyramide, fluoxetine, clarithromycin, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, monoamine oxidase inhibitors, and beta adrenergic blocking agents. (Fachinformation zu Glibenclamid, Arzneimittelwechselwirkungen)

  • GlimepiridSulfonylharnstoffMittelschwer

    …steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides, chloramphenicol, coumarins, probenecid and monoamine oxidase inhibitors. (Fachinformation zu Glimepirid, Arzneimittelwechselwirkungen)

  • GlipizidSulfonylharnstoffMittelschwer

    …antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogs (e.g., octreotide), sulfonamide antibiotics, nonsteroidal anti-inflammatory agents, chloramphenicol, probenecid, coumarins, voriconazole, H2 receptor… (Fachinformation zu Glipizid, Arzneimittelwechselwirkungen)

  • Glipizid und MetforminSulfonylharnstoffMittelschwer

    Glipizide: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs, including nonsteroidal anti-inflammatory agents, some azoles, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta-adrenergic blocking agents. (Fachinformation zu Glipizid und Metformin, Vorsichtsmaßnahmen)

  • GriseofulvinAntimykotikumMittelschwer

    Serum salicylate concentrations may be decreased when griseofulvin is given concomitantly with salicylates. (Fachinformation zu Griseofulvin, Arzneimittelwechselwirkungen)

  • Humaninsulin (Normalinsulin)InsulinMittelschwer

    …agents, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blocking Agents, Disopyramide, Fibrates, Fluoxetine, Monoamine Oxidase Inhibitors, Pentoxifylline, Pramlintide, Salicylates, Somatostatin Analogs (e.g., octreotide), and Sulfonamide Antibiotics Prevention or Management Monitor blood glucose more frequently and modify AFREZZA dosage, as clinically… (Fachinformation zu Humaninsulin (Normalinsulin), Arzneimittelwechselwirkungen)

  • HyaluronidaseMittelschwer

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (Fachinformation zu Hyaluronidase, Arzneimittelwechselwirkungen)

  • HydrocortisonKortikosteroidMittelschwer

    The clearance of salicylates may be increased with concurrent use of corticosteroids; this could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn. (Fachinformation zu Hydrocortison, Arzneimittelwechselwirkungen)

  • Insulin aspartInsulinMittelschwer

    Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics. (Fachinformation zu Insulin aspart, Arzneimittelwechselwirkungen)

  • Insulin degludecInsulinMittelschwer

    …May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors. (Fachinformation zu Insulin degludec, Arzneimittelwechselwirkungen)

  • Insulin detemirInsulinMittelschwer

    …May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors. (Fachinformation zu Insulin detemir, Arzneimittelwechselwirkungen)

  • Insulin glarginInsulinMittelschwer

    …May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors. (Fachinformation zu Insulin glargin, Arzneimittelwechselwirkungen)

  • Insulin lisproInsulinMittelschwer

    Clinically Significant Drug Interactions with LYUMJEV Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics. (Fachinformation zu Insulin lispro, Arzneimittelwechselwirkungen)

  • KetorolacNSARMittelschwer

    Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to 10 mcg/mL. (Fachinformation zu Ketorolac, Arzneimittelwechselwirkungen)

  • Levonorgestrel und Ethinylestradiolorales KontrazeptivumMittelschwer

    Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam. (Fachinformation zu Levonorgestrel und Ethinylestradiol, Arzneimittelwechselwirkungen)

  • LevothyroxinSchilddrüsenhormonMittelschwer

    An initial increase in serum FT 4 is followed by return of FT 4 to normal levels with sustained therapeutic serum salicylate concentrations, although total T 4 levels may decrease by as much as 30%. (Fachinformation zu Levothyroxin, Arzneimittelwechselwirkungen)

  • LiothyroninSchilddrüsenhormonMittelschwer

    An initial increase in serum FT4 is followed by return of FT4 to normal levels with sustained therapeutic serum salicylate concentrations, although total T4 levels may decrease by as much as 30%. (Fachinformation zu Liothyronin, Arzneimittelwechselwirkungen)

  • MethotrexatImmunsuppressivumMittelschwer

    Caution should be used when NSAIDs and salicylates are administered concomitantly with lower doses of methotrexate, including XATMEP. (Fachinformation zu Methotrexat, Arzneimittelwechselwirkungen)

  • MethylprednisolonKortikosteroidMittelschwer

    The clearance of salicylates may be increased with concurrent use of corticosteroids. (Fachinformation zu Methylprednisolon, Arzneimittelwechselwirkungen)

  • MetolazonThiaziddiuretikumMittelschwer

    Salicylates And Other Non-Steroidal Anti-Inflammatory Drugs May decrease the antihypertensive effects of metolazone tablets, USP. (Fachinformation zu Metolazon, Arzneimittelwechselwirkungen)

  • NateglinidGlinidMittelschwer

    …with Nateglinide Drugs That May Increase the Blood-Glucose-Lowering Effect of Nateglinide and Susceptibility to Hypoglycemia Drugs: Nonsteroidal anti-inflammatory drugs (NSAIDs), salicylates, monoamine oxidase inhibitors, non-selective beta-adrenergic-blocking agents, anabolic hormones (e.g., methandrostenolone), guanethidine, gymnema sylvestre, glucomannan,… (Fachinformation zu Nateglinid, Arzneimittelwechselwirkungen)

  • Hyperventilation and Metabolic Acidosis: Sodium Phenylacetate and Sodium Benzoate Injection may cause side effects typically associated with salicylate overdose, such as hyperventilation and metabolic acidosis. (Fachinformation zu Natriumphenylacetat und Natriumbenzoat, Warnhinweise und Vorsichtsmaßnahmen)

  • NizatidinH2-BlockerMittelschwer

    In patients given very high doses (3,900 mg) of aspirin daily, increases in serum salicylate levels were seen when nizatidine, 150 mg b.i.d., was administered concurrently. (Fachinformation zu Nizatidin, Arzneimittelwechselwirkungen)

  • CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam. (Fachinformation zu Norelgestromin und Ethinylestradiol, Arzneimittelwechselwirkungen)

  • Norgestimat und Ethinylestradiolorales KontrazeptivumMittelschwer

    COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine. (Fachinformation zu Norgestimat und Ethinylestradiol, Arzneimittelwechselwirkungen)

  • Norgestrel und Ethinylestradiolorales KontrazeptivumMittelschwer

    COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine. (Fachinformation zu Norgestrel und Ethinylestradiol, Arzneimittelwechselwirkungen)

  • PhenytoinAntiepileptikumMittelschwer

    …sulfaphenazole, sulfadiazine, sulfamethoxazole-trimethoprim Other Acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen, fluvastatin, isoniazid, methylphenidate, phenothiazines, salicylates, ticlopidine, tolbutamide, trazodone, warfarin Drugs that may decrease phenytoin serum levels Antacids Antacids may affect absorption of phenytoin. (Fachinformation zu Phenytoin, Arzneimittelwechselwirkungen)

  • Pioglitazon und GlimepiridThiazolidindion (Glitazon)Mittelschwer

    …steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides, chloramphenicol, coumarins, probenecid and monoamine oxidase inhibitors. (Fachinformation zu Pioglitazon und Glimepirid, Arzneimittelwechselwirkungen)

  • PrednisolonKortikosteroidMittelschwer

    NSAIDS, including aspirin and salicylates: Concomitant use of aspirin or other non-steroidal anti-inflammatory agents and corticosteroids increases the risk of gastrointestinal side effects. (Fachinformation zu Prednisolon, Arzneimittelwechselwirkungen)

  • PrednisonKortikosteroidMittelschwer

    NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (Fachinformation zu Prednison, Arzneimittelwechselwirkungen)

  • SalsalatNSARMittelschwer

    ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO SALSALATE AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. (Fachinformation zu Salsalat, Arzneimittelwechselwirkungen)

  • SulfadiazinSulfonamidMittelschwer

    Conversely, agents such as indomethacin, probenecid and salicylates may displace sulfonamides from plasma albumin and increase the concentrations of free drug in plasma. (Fachinformation zu Sulfadiazin, Arzneimittelwechselwirkungen)

  • TorasemidSchleifendiuretikumMittelschwer

    Nonsteroidal Anti-Inflammatory Drugs Because torsemide and salicylates compete for secretion by renal tubules, patients receiving high doses of salicylates may experience salicylate toxicity when torsemide is concomitantly administered. (Fachinformation zu Torasemid, Arzneimittelwechselwirkungen)

  • TriamcinolonKortikosteroidMittelschwer

    The clearance of salicylates may be increased with concurrent use of corticosteroids. (Fachinformation zu Triamcinolon, Arzneimittelwechselwirkungen)

  • VortioxetinAntidepressivumMittelschwer

    Coadministration of aspirin 150 mg/day with multiple daily doses of TRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid [see Clinical Pharmacology (12.3) ] . (Fachinformation zu Vortioxetin, Arzneimittelwechselwirkungen)

Geringfügige Erwähnungen (4)

  • DoxycyclinTetracyclin-AntibiotikumGeringfügig

    Absorption of tetracyclines, including doxycycline hyclate is impaired by antacids containing aluminum, calcium, or magnesium, bismuth subsalicylate and iron-containing preparations. (Fachinformation zu Doxycyclin, Arzneimittelwechselwirkungen)

  • EnoxaparinAntikoagulans (Gerinnungshemmer)Geringfügig

    These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone. (Fachinformation zu Enoxaparin, Arzneimittelwechselwirkungen)

  • EntacaponGeringfügig

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (Fachinformation zu Entacapon, Vorsichtsmaßnahmen)

  • RepaglinidGlinidGeringfügig

    Examples: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, nonsteroidal anti-inflammatory agents (NSAIDs), pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics. (Fachinformation zu Repaglinid, Arzneimittelwechselwirkungen)

Prüfen Sie Bismutsubsalicylat gegen alles, was Sie einnehmen. Fügen Sie Ihre gesamte Liste hinzu; alle Paare werden auf einmal geprüft.

Im Wechselwirkungscheck öffnen

Keine medizinische Beratung. Der Schweregrad gibt die Formulierung der Fachinformation wieder, nicht Ihre persönlichen Umstände. Eine als „schwerwiegend“ eingestufte Wechselwirkung kann unter Aufsicht Routine sein, und eine „geringfügige“ kann bei hohen Dosen von Bedeutung sein. Fragen Sie in einer Apotheke nach.